EGLN1 and myocardial infarction: Gene therapy for myocardial infarction: Gene therapy using PNPs or cationic microbubbles to deliver siRNA or shRNA against PHD2 can improve angiogenesis, reduce infarct size, and enhance cardiac function post-myocardial infarction.